Atlas Trials

Primary Cutaneous Anaplastic Large Cell Lymphoma

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Cutaneous Anaplastic Large Cell Lymphoma

RecordFirmDate
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma (NCT03409432)John Reneau2018-03-16
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715)Mayo Clinic2016-01-19
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency (NCT01787409)Mayo Clinic2013-03-06
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) (NCT01578499)Millennium Pharmaceuticals, Inc.2012-06-11

Track Primary Cutaneous Anaplastic Large Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.